Vericel Corp (VCEL)
56.71
-0.55
(-0.96%)
USD |
NASDAQ |
Nov 21, 16:00
56.72
+0.01
(+0.02%)
After-Hours: 20:00
Vericel 1 Year Total Returns (Daily): 58.05% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 58.05% |
November 20, 2024 | 56.15% |
November 19, 2024 | 52.62% |
November 18, 2024 | 44.59% |
November 15, 2024 | 45.58% |
November 14, 2024 | 43.51% |
November 13, 2024 | 63.39% |
November 12, 2024 | 64.82% |
November 11, 2024 | 67.44% |
November 08, 2024 | 53.10% |
November 07, 2024 | 37.03% |
November 06, 2024 | 32.89% |
November 05, 2024 | 21.41% |
November 04, 2024 | 20.37% |
November 01, 2024 | 25.69% |
October 31, 2024 | 25.18% |
October 30, 2024 | 32.46% |
October 29, 2024 | 39.64% |
October 28, 2024 | 39.12% |
October 25, 2024 | 27.40% |
October 24, 2024 | 21.00% |
October 23, 2024 | 26.13% |
October 22, 2024 | 26.03% |
October 21, 2024 | 24.07% |
October 18, 2024 | 20.79% |
Date | Value |
---|---|
October 17, 2024 | 14.02% |
October 16, 2024 | 22.97% |
October 15, 2024 | 32.92% |
October 14, 2024 | 33.36% |
October 11, 2024 | 24.34% |
October 10, 2024 | 15.40% |
October 09, 2024 | 19.18% |
October 08, 2024 | 21.30% |
October 07, 2024 | 20.45% |
October 04, 2024 | 27.75% |
October 03, 2024 | 22.74% |
October 02, 2024 | 22.63% |
October 01, 2024 | 19.48% |
September 30, 2024 | 26.04% |
September 27, 2024 | 21.59% |
September 26, 2024 | 31.55% |
September 25, 2024 | 30.00% |
September 24, 2024 | 31.59% |
September 23, 2024 | 36.38% |
September 20, 2024 | 43.20% |
September 19, 2024 | 42.65% |
September 18, 2024 | 36.52% |
September 17, 2024 | 29.25% |
September 16, 2024 | 30.42% |
September 13, 2024 | 24.92% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-64.08%
Minimum
Jun 28 2022
650.9%
Maximum
Mar 23 2021
46.84%
Average
25.69%
Median
1 Year Total Returns (Daily) Benchmarks
Catalyst Pharmaceuticals Inc | 53.71% |
Exelixis Inc | 64.14% |
Halozyme Therapeutics Inc | 17.54% |
ADMA Biologics Inc | 440.6% |
Natera Inc | 213.9% |